Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Olivia Yang
CONTACT
Lead
Beijing InnoCare Pharma Tech Co., Ltd.
Part I (Phase I) of the study enrolls patients with advanced solid tumors (9-15 patients); Part II (Phase II) of the study enrolls patients with urothelial carcinoma or cholangiocarcinoma with FGFR genetic alterations (30 patients).
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted